Can NIPT Be Wrong About 47,XYY Syndrome?

47,XYY syndrome (also known as Jacob’s syndrome) is a genetic condition where a male is born with an extra Y chromosome. The symptoms are often mild; individuals typically have a taller stature and may experience learning differences or hypotonia (low muscle tone), but they generally lead typical, healthy lives.

A high-risk result on a Non-Invasive Prenatal Test (NIPT) does not mean your baby definitely has 47,XYY syndrome. NIPT is a screening test, not a diagnostic test ^[1]. This means it is designed to flag pregnancies that might have a higher chance of a genetic difference, but it cannot give you a definitive “yes” or “no” answer ^[2]. While it is an advanced and useful tool, it is entirely possible for the NIPT to be wrong—a situation known as a false positive ^[3].

Why False Positives Happen

To understand why NIPT can be wrong, it helps to know how the test works. NIPT looks at fragments of DNA floating in the pregnant person’s bloodstream. However, this DNA does not come directly from the baby; it comes from the placenta (the organ that provides oxygen and nutrients to the growing baby) ^[4]. Because the test is analyzing placental DNA, a few specific biological situations can cause the test to flag a high risk for XYY even when the baby does not have it:

• Confined Placental Mosaicism (CPM): This is the most common reason for a false positive ^[3]. In CPM, the cells in the placenta have an extra Y chromosome (XYY), but the cells in the baby itself are typical (XY) ^[4]. The NIPT accurately detects the extra Y from the placenta, but incorrectly assumes the baby also has it ^[5].
• A Vanishing Twin: Sometimes, a pregnancy starts with twins, but one twin stops developing very early on (often before you even know you were carrying twins). If the “vanishing” twin had 47,XYY, its DNA can remain in your bloodstream and cause a high-risk result for the surviving, typical baby ^[6][7].

Understanding Your Actual Risk (PPV)

When looking at an NIPT result, the most important number is the Positive Predictive Value (PPV). The PPV tells you: Out of all the people who get a high-risk result for XYY, how many of those babies actually have XYY?

NIPT was originally designed to screen for conditions like Down syndrome, for which it has a very high PPV. The PPV for sex chromosome differences, however, is generally lower ^[8]. While NIPT is better at predicting 47,XYY than it is at predicting some other sex chromosome conditions (like Turner syndrome) ^[9][10], false positives are still a well-recognized limitation of the test ^[11].

The PPV varies significantly depending on the laboratory that performed your test and your unique clinical picture. Some clinical literature reports PPVs for 47,XYY anywhere from 70% up to 100% in specific testing cohorts ^[12][9]. Because this number can be confusing to pinpoint, genetic counselors often use specialized online PPV calculators (such as those provided by the Perinatal Quality Foundation) to give you a personalized risk assessment based on the exact brand of test you took.

How to Know for Sure

Because NIPT cannot give you a definitive diagnosis, major medical guidelines strongly recommend that no permanent or irreversible clinical decisions be made based solely on an NIPT result ^[13][2]. To know for sure if your baby has 47,XYY syndrome, you need diagnostic testing ^[14].

You generally have two options for diagnostic testing:

1. Testing during pregnancy: You can undergo an invasive procedure to test the pregnancy tissue, though both options carry a very small risk of miscarriage that you should discuss with your doctor.
   • Chorionic Villus Sampling (CVS): This tests a tiny piece of the placenta and can typically be performed earlier in pregnancy (around 10 to 13 weeks). However, this comes with an important warning: Because CVS tests the placenta, it could potentially return the exact same false positive as the NIPT if the cause is Confined Placental Mosaicism ^[4].
   • Amniocentesis: This tests the amniotic fluid and is usually performed starting around 15 to 16 weeks of pregnancy. Amniocentesis is strongly preferred for confirming sex chromosome differences because it tests cells shed directly by the baby, completely bypassing the risk of Confined Placental Mosaicism ^[2][15].
2. Testing after birth: If you prefer not to accept the small miscarriage risk associated with an invasive procedure, or if the diagnosis will not change your pregnancy management, you can wait and test the baby after birth using a simple blood draw or cheek swab (a karyotype or microarray).

Speaking with a genetic counselor or a maternal-fetal medicine specialist is highly recommended ^[16]. They can help you calculate your exact PPV, explain the timeline and trade-offs of your testing options, and help you decide the best next steps for your family.